Why Centralize Spirometry Data?
Tuesday, March 5 2013
Location: Live webcast
As the primary and secondary end points in a majority of pulmonary clinical trials, obtaining high quality pulmonary function data is of paramount importance. While variability is inherent in such
effort dependent testing, engaging the centralization and professional review services of an experienced clinical trial service provider can increase reproducibility and quality of data captured creating cost efficiencies.
- How centralized spirometry can improve clinical data
- Reducing study costs by centralizing data
- Quality issues impacting spirometry data
- International guidelines for quality
- Challenges in centralized spirometry trials
Scott Burcham, RRT Executive Director, Pulmonary Services Biomedical Systems
Mr. Burcham has served as Biomedical Systems’ Executive Director of Pulmonary Services since 1994 and brings over 16 years of clinical trial expertise in addition to 30 years of experience as a Registered Respiratory Therapist. As an expert in the centralization of pulmonary function data, he has been instrumental in developing many products available for centralizing and processing pulmonary function data in clinical trials. Mr. Burcham is an active member of the American Thoracic Society (ATS), European Respiratory Society (ERS), and the American Association for Respiratory Care (AARC).